THE ONCOLOGY INSTITUTE INC. - COMMON STOCK
0.8400
07-February-25 15:34:28
15 minutes delayed
Stocks
-0.0482
-5.43%
Today's range
0.7902 - 0.8799
ISIN
N/A
Source
NASDAQ
-
The Oncology Institute to Participate at Upcoming Investor Conferences
27 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
20 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
25 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
08 Nov 2023 16:05:01 By Nasdaq GlobeNewswire
-
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
18 Oct 2023 08:03:01 By Nasdaq GlobeNewswire
-
The Oncology Institute Names Jeremy Castle as Chief Operations Officer
11 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
-
The Oncology Institute Regains Compliance with Nasdaq Listing Requirements
18 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2023 16:40:50 By Nasdaq GlobeNewswire
-
The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations
31 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call
18 Jul 2023 08:00:02 By Nasdaq GlobeNewswire
-
The Oncology Institute Announces Leadership Transition
12 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
09 Jun 2023 08:00:43 By Nasdaq GlobeNewswire
-
The Oncology Institute to Open Project Southland
07 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting
31 May 2023 08:01:00 By Nasdaq GlobeNewswire
-
The Oncology Institute to Participate at Upcoming Investor Conferences
31 May 2023 08:00:38 By Nasdaq GlobeNewswire
-
10 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer
02 May 2023 08:00:01 By Nasdaq GlobeNewswire